As of 2025-10-16, the Intrinsic Value of Landos Biopharma Inc (LABP) is -39.61 USD. This LABP valuation is based on the model Peter Lynch Fair Value. With the current market price of 22.93 USD, the upside of Landos Biopharma Inc is -272.74%.
Based on its market price of 22.93 USD and our intrinsic valuation, Landos Biopharma Inc (LABP) is overvalued by 272.74%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -39.61 - -39.61 | -39.61 | -272.74% |
P/E | (72.09) - (101.72) | (99.03) | -531.9% |
DDM - Stable | (62.41) - (201.00) | (131.71) | -674.4% |
DDM - Multi | (48.48) - (125.02) | (70.29) | -406.5% |
Market Cap (mil) | 71.77 |
Beta | 0.70 |
Outstanding shares (mil) | 3.13 |
Enterprise Value (mil) | 42.77 |
Market risk premium | 4.60% |
Cost of Equity | 10.22% |
Cost of Debt | 5.00% |
WACC | 6.94% |